TB Survivor Calls On USAID To Expand Support For Global Health R&D

In a post in the Global Health Technologies Coalition’s “Breakthroughs” blog, part of a “new blog series to highlight the impact of USAID’s commitment to global health research and development (R&D),” Natalie Nelson, a tuberculosis (TB) survivor from Tennessee, in a Q&A calls for USAID to expand its support for health R&D to include TB vaccine research so “the agency [can] help change the lives of TB patients like her worldwide.” She discusses her personal experience with TB, reflects on “the growing issue of resistance to currently available TB treatment options,” and examines “how … new and improved vaccines — as well as treatment options — [could] help in the fight against TB worldwide,” among other topics (Lufkin, 12/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.